Anti-HER2 Biparatopic ADC JSKN003 Has Been Granted Breakthrough-Therapy Designation for the Treatment of PROC
SUZHOU, China, March 18, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been...
Experience the Future of Gaming: Tencent Games Brings Innovative Game Technologies to GDC 2025
SAN FRANCISCO, March 13, 2025 /PRNewswire/ -- In anticipation of the 2025 Game Developers Conference (GDC), Tencent Games, the world's leading platform for game development, publishing and operations, today announced it will showcase its innovative...
Tencent Cloud, Anti-Cheat Expert (ACE) and Asphere Join Forces to Ensure Fair Game Play
HONG KONG, March 11, 2025 /PRNewswire/ -- Tencent Cloud, the cloud business of global leading technology company Tencent, and Anti-Cheat Expert (ACE), Tencent's professional game security solution, announced the partnership with Asphere, an...
ScamAdviser at MWC 2025: Addressing the Rising Threat of AI-Powered Scams
BARCELONA, Spain, March 5, 2025 /PRNewswire/ -- ScamAdviser, a leading brand in global enterprise scam prevention solutions, spotlighted the escalating threat of AI-driven scams at Mobile World Congress (MWC) 2025 during the "GASA x ScamAdviser...
Tencent Cloud Recognized as a Leader in Omdia Market Radar for Games in Asia & Oceania, Solidifying its Position as a Global Gaming Industry Innovator
HONG KONG, Feb. 27, 2025 /PRNewswire/ -- Tencent Cloud, the cloud business of global leading technology company Tencent, has been named as a leader among cloud platforms for games in the latest report by Omdia, a premier technology research and...
Anti-HER2 Bispecific ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for the Treatment of HER2-positive Breast Cancer
SUZHOU, China, Feb. 6, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, Jan. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
2024 Global Healthy Longevity Conference Successfully Held
SHENZHEN, China, Nov. 20, 2024 /PRNewswire/ -- The 2024 Global Healthy Longevity Conference took place successfully in Shenzhen from 15-17 November. Under the theme "The Healthy Longevity Era: Technology-driven Anti-Aging," the conference combined...
